Atlassian (NASDAQ:TEAM) Price Target Lowered to $105.00 at BMO Capital Markets

Atlassian (NASDAQ:TEAM) had its price objective trimmed by BMO Capital Markets from $130.00 to $105.00 in a research note issued to investors on Friday morning, MarketBeat reports. The firm currently has an outperform rating on the technology company’s stock.

TEAM has been the subject of several other research reports. TD Cowen lowered their price target on shares of Atlassian from $140.00 to $85.00 and set a “hold” rating for the company in a research report on Thursday, April 16th. Canaccord Genuity Group lowered their price target on shares of Atlassian from $185.00 to $150.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Oppenheimer lowered their price target on shares of Atlassian from $150.00 to $100.00 and set an “outperform” rating for the company in a research report on Friday, April 17th. Citigroup lowered their price target on shares of Atlassian from $160.00 to $110.00 and set a “buy” rating for the company in a research report on Friday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $98.00 price target on shares of Atlassian in a research report on Monday. Twenty-one analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $144.67.

Atlassian Trading Up 29.6%

TEAM stock traded up $20.29 during mid-day trading on Friday, reaching $88.88. The company had a trading volume of 27,361,284 shares, compared to its average volume of 7,734,163. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.89 and a quick ratio of 0.89. The company has a market capitalization of $23.44 billion, a PE ratio of -123.44 and a beta of 0.99. The firm has a 50 day moving average of $70.97 and a 200 day moving average of $118.12. Atlassian has a 12 month low of $56.01 and a 12 month high of $232.36.

Atlassian (NASDAQ:TEAM) last issued its earnings results on Thursday, April 30th. The technology company reported $1.75 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.42. The business had revenue of $1.79 billion for the quarter, compared to the consensus estimate of $1.70 billion. Atlassian had a negative net margin of 3.50% and a positive return on equity of 5.62%. The company’s revenue for the quarter was up 31.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.97 EPS. On average, equities analysts predict that Atlassian will post -0.01 earnings per share for the current fiscal year.

Insider Activity at Atlassian

In related news, CFO Joseph Leo Binz sold 1,653 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $81.35, for a total transaction of $134,471.55. Following the completion of the sale, the chief financial officer owned 208,639 shares of the company’s stock, valued at $16,972,782.65. This represents a 0.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Scott Farquhar sold 7,665 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $94.81, for a total transaction of $726,718.65. Following the sale, the director directly owned 275,940 shares of the company’s stock, valued at $26,161,871.40. The trade was a 2.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 52,003 shares of company stock valued at $5,338,804 over the last three months. Company insiders own 36.66% of the company’s stock.

Institutional Investors Weigh In On Atlassian

Hedge funds and other institutional investors have recently bought and sold shares of the company. MV Capital Management Inc. purchased a new stake in Atlassian during the fourth quarter valued at approximately $25,000. Physician Wealth Advisors Inc. lifted its position in Atlassian by 60.4% during the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after acquiring an additional 61 shares during the last quarter. Atlantic Union Bankshares Corp lifted its position in Atlassian by 19,900.0% during the third quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after acquiring an additional 199 shares during the last quarter. Board of the Pension Protection Fund purchased a new position in shares of Atlassian in the fourth quarter worth $32,000. Finally, Basepoint Wealth LLC purchased a new position in shares of Atlassian in the fourth quarter worth $32,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Trending Headlines about Atlassian

Here are the key news stories impacting Atlassian this week:

• Positive Sentiment: Q3 beat and raised revenue guidance — Atlassian reported ~32% revenue growth (roughly $1.8B) and beat EPS estimates, then lifted its FY revenue growth target, which is the main catalyst for the rally. Read More.
• Positive Sentiment: Strong execution driven by cloud, AI and enterprise expansion — Management pointed to AI features, cloud migrations and growing enterprise adoption (including Rovo usage) as sustainable growth drivers. Read More.
• Positive Sentiment: Street praise and sector lift — Multiple outlets and analysts praised the quarter; the results helped lift other beaten‑down SaaS names as investors reassess demand risk for enterprise software. Read More.
• Neutral Sentiment: Mixed analyst/Wall Street reactions — Some commentators called the results “solid,” while others raised questions about margin and longer‑term software pricing compression; expect divergent sell‑side takes to continue. Read More.
• Neutral Sentiment: Marketplace/venture news — Atlassian Ventures invested in Riffle and a new app launched on the Atlassian Marketplace, supporting ecosystem growth but with limited near‑term revenue impact. Read More.
• Negative Sentiment: Some price‑target cuts and a neutral/tempered tone — UBS cut its target to $95 and moved to a neutral rating, which could weigh on upside expectations near term. Read More.
• Negative Sentiment: Other target resets — BMO and Piper Sandler lowered targets (BMO to $105, Piper Sandler to $175) even as some keep outperform/overweight stances; these mixed cuts reflect caution on medium‑term multiples despite the beat. Read More.

Atlassian Company Profile

Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.

Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.